Changes in the maternal hypothalamic-pituitary-adrenal axis in pregnancy and postpartum: Influences on maternal and fetal outcomes

Neuroendocrinology

Volumn 98, Issue 2, 2013, Pages 106-115

  Duthie, Leanne ^a   Reynolds, Rebecca M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

HPA axis; Mood; Pregnancy; Programming

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 2; CORTICOTROPIN; GLUCOCORTICOID; HYDROCORTISONE;

ARTICLE; CARDIOMETABOLIC RISK; CORRELATION ANALYSIS; DELIVERY; DEVELOPMENTAL DISORDER; DRUG EFFECT; DRUG EXPOSURE; ENZYME ACTIVITY; FETUS OUTCOME; GESTATIONAL AGE; HIGH RISK PATIENT; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LOW BIRTH WEIGHT; MATERNAL STRESS; MOOD DISORDER; MOTHER; NERVE CELL DIFFERENTIATION; NONHUMAN; PATHOPHYSIOLOGY; PREGNANCY; PRIORITY JOURNAL; PROGENY; PUERPERIUM;

ANIMALS; FEMALE; FETUS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFANT, NEWBORN; MOTHERS; PITUITARY-ADRENAL SYSTEM; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY OUTCOME;

EID: 84886396060     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000354702     Document Type: Article

References (142)

1. Barker DJ: The fetal origins of coronary heart disease. Acta Paediatr Suppl 1997; 422: 78-82.
2. Barker DJP, et al: The relation of small head circumference and thinness at birth to death from cardiovascular disease in adult life. BMJ 1993; 306: 422-426.
3. Law CM, et al: Thinness at birth and glucose intolerance in 7-year-old children. Diabet Med 1995; 12: 24-29.
4. Hales CN, et al: Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 1991; 303: 1019-1022.
5. Roseboom TJ, et al: Coronary heart disease after prenatal exposure to the Dutch famine, 1944-1945. Heart 2000; 84: 595-598.
6. Ravelli ACJ, et al: Glucose tolerance in adults after prenatal exposure to famine. Lancet 1998; 351: 173-177.
7. Stanner SA, et al: Does malnutrition in utero determine diabetes and coronary heart disease in adulthood? Results from the Leningrad siege study, a cross-sectional study. BMJ 1997; 315: 1342-1349.
8. Reynolds RM: Glucocorticoid excess and the developmental origins of disease: Two decades of testing the hypothesis-2012 Curt Richter Award Winner. Psychoneuroendocrinology 2013; 38: 1-11.
9. Seckl JR: Prenatal glucocorticoids and longterm programming. Eur J Endocrinol 2004; 151(suppl 3):U49-U62.
10. Nyirenda MJ, et al: Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring. J Clin Invest 1998; 101: 2174-2181.
11. Moss TJ, et al: Programming effects in sheep of prenatal growth restriction and glucocorticoid exposure. Am J Physiol Regul Integr Comp Physiol 2001; 281:R960-R970.
12. McArthur S, et al: Perinatal glucocorticoid treatment disrupts the hypothalamo-lactotroph axis in adult female, but not male, rats. Endocrinology 2006; 147: 1904-1915.
13. Dodic M, et al: Programming effects of short prenatal exposure to dexamethasone in sheep. Hypertension 2002; 40: 729-734.
14. Dodic M, et al: An early prenatal exposure to excess glucocorticoid leads to hypertensive offspring in sheep. Clin Sci (Lond) 1998; 94: 149-155.
15. Ortiz LA, et al: Prenatal dexamethasone programs hypertension and renal injury in the rat. Hypertension 2003; 41: 328-334.
16. De Blasio MJ, et al: Maternal exposure to dexamethasone or cortisol in early pregnancy differentially alters insulin secretion and glucose homeostasis in adult male sheep offspring. Am J Physiol 2007; 293: 75-82.
17. Kleinhaus K, et al: Effects of excessive glucocorticoid receptor stimulation during early gestation on psychomotor and social behavior in the rat. Dev Psychobiol 2010; 52: 121-132.
18. Oliveira M, et al: Induction of a hyperanxious state by antenatal dexamethasone: A case for less detrimental natural corticosteroids. Biol Psychiatry 2006; 59: 844-852.
19. Hauser J, et al: Effects of prenatal dexamethasone treatment on physical growth, pituitaryadrenal hormones, and performance of motor, motivational, and cognitive tasks in juvenile and adolescent common marmoset monkeys. Endocrinology 2008; 149: 6343-6355.
20. Kelly BA, et al: Antenatal glucocorticoid exposure and long-term alterations in aortic function and glucose metabolism. Pediatrics 2012; 129: 1282-1290.
21. Doyle LW, et al: Antenatal corticosteroid therapy and blood pressure at 14 years of age in preterm children. Clin Sci 2000; 98: 137-142.
22. Sandman CA, et al: Maternal corticotropinreleasing hormone and habituation in the human fetus. Dev Psychobiol 1999; 34: 163-173.
23. De Weerth C, van Hees Y, Buitelaar JK: Prenatal maternal cortisol levels and infant behavior during the first 5 months. Early Hum Dev 2003; 74: 139-151.
24. Rotmensch C, et al: The effect of antenatal steroid administration on the fetal response to vibroacoustic stimulation. Acta Obstet Gynecol Scand 1999; 78: 847-851.
25. Huttunen MO, et al: Prenatal loss of father and psychiatric disorders. Arch Gen Psychiatry 1978; 35: 429-431.
26. Imamura Y, et al: Life-time prevalence of schizophrenia among individuals prenatally exposed to atomic bomb radiation in Nagasaki. Acta Psychiatr Scand 1999; 100: 344-349.
27. Izumoto Y, et al: Schizophrenia and the influenza epidemics of 1957 in Japan. Biol Psychiatry 1999; 46: 119-124.
28. Kinney DK, et al: Increased relative risk for schizophrenia and prenatal exposure to a severe tornado. Schizophr Res 1999; 13: 45-46.
29. Kunugi H, Nanko S, Takei N, Saito K, Hayashi N, Kazamatsuri H: Schizophrenia following in utero exposure to the 1957 influenza epidemics in Japan. Am J Psychiatry 1995; 152: 450-452.
30. Yeragani VK, et al: The incidence of abnormal dexamethasone suppression in schizophrenia: A review and a meta-analysis comparison with the incidence in normal controls. Can J Psychiatry 1990; 35: 128-132.
31. Koenig JI, et al: Glucocorticoid hormones and early brain development in schizophrenia. Neuropsychopharmacology 2002; 27: 309-318.
32. Clements AD, et al: The incidence of attention deficit-hyperactivity disorder in children whose mothers experienced extreme psychological stress. Ga Educ Res 1992; 91: 1-14.
33. Van Os J, et al: Prenatal exposure to maternal stress and subsequent schizophrenia: The May 1940 invasion of The Netherlands. Br J Psychiatry 1998; 172: 324-326.
34. MacArthur BA, et al: School progress and cognitive development of 6-year-old children whose mothers were treated antenatally with betamethasone. Pediatrics 1982; 70: 99-105.
35. Jung C, et al: A longitudinal study of plasma and urinary cortisol in pregnancy and postpartum. J Clin Endocrinol Metab 2011; 96: 1533-1540.
36. Qureshi AC, et al: The influence of the route of oestrogen administration on serum levels of cortisol-binding globulin and total cortisol. Clin Endocrinol 2007; 66: 632-635.
37. Demey-Ponsart E, et al: Serum CBG, free and total cortisol and circadian patterns of adrenal function in normal pregnancy. J Steroid Biochem 1982; 16: 165-169.
38. Hillhouse EW, et al: The identification of human myometrial corticotropin-releasing hormone receptor that increases in affinity during pregnancy. J Clin Endocrinol Metabol 1993; 76: 736-741.
39. Reis FM, et al: Putative role of placental corticotropin-releasing factor in the mechanism of human parturition. J Soc Gynecol Invest 1999; 6: 109-118.
40. Petraglia F, et al: Corticotropin-releasing factor-binding protein is produced by human placenta and intrauterine tissues. J Clin Endocrinol Metab 1993; 77: 919-924.
41. Robinson BG, et al: Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta. Proc Natl Acad Sci USA 1988; 85: 5244-5248.
42. Mastorakos G, Ilias I: Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum. Ann NY Acad Sci 2003; 997: 136-149.
43. Entringer S, et al: Ecological momentary assessment of maternal cortisol profiles over a multiple-day period predicts the length of human gestation. Psychosom Med 2011; 73: 469-474.
44. De Weerth C, Buitelaar JK: Physiological stress reactivity in human pregnancy-a review. Neurosci Biobehav Rev 2005; 29: 295-312.
45. Kammerer M, et al: Pregnant women become insensitive to cold stress. BMC Pregnancy Childbirth 2002; 2: 8.
46. Wadhwa PD, et al: Placental CRH modulates maternal pituitary adrenal function in human pregnancy. Ann NY Acad Sci 1997; 814: 276-281.
47. Benediktsson R, et al: Placental 11-hydroxysteroid dehydrogenase: A key regulator of fetal glucocorticoid exposure. Clin Endocrinol 1997; 46: 161-166.
48. Murphy BEP, et al: Conversion of maternal cortisol to cortisone during placental transfer to the human fetus. Am J Obstet Gynecol 1974; 118: 538-541.
49. Lopez-Bernal A, et al: 11-Hydroxysteroid dehydrogenase activity (EC1.1.1.146) in human placenta and decidua. J Steroid Biochem 1980; 13: 1081-1087.
50. Gitau R, Fisk NM, Glover V: Human fetal and maternal corticotrophin-releasing hormone responses to acute stress. Arch Dis Child Fetal Neonatal Ed 2004; 89:F29-F32.
51. O'Donnell KJ, et al: Maternal prenatal anxiety and downregulation of placental 11-HSD2. Psychoneuroendocrinology 2012; 37: 818-826.
52. Welberg LA, et al: Chronic maternal stress inhibits the capacity to up-regulate placental 11-hydroxysteroid dehydrogenase type 2 activity. J Endocrinol 2005; 186:R7-R12.
53. Mairesse J, et al: Maternal stress alters endocrine function of the feto-placental unit in rats. Am J Physiol Endocrinol Metab 2007; 292: 1526-1533.
54. Glover V, et al: Association between maternal and amniotic fluid cortisol is moderated by maternal anxiety. Psychoneuroendocrinology 2009; 34: 430-435.
55. Ponder KL, et al: Maternal depression and anxiety are associated with altered gene expression in the human placenta without modification by antidepressant use: Implications for fetal programming. Dev Psychobiol 2011; 53: 711-723.
56. Johnstone JF, et al: The effects of chorioamnionitis and betamethasone on 11-hydroxysteroid dehydrogenase types 1 and 2 and the glucocorticoid receptor in preterm human placenta. J Soc Gynecol Investig 2005; 12: 238-245.
57. Kossintseva I, et al: Proinflammatory cytokines inhibit human placental 11-hydroxysteroid dehydrogenase type 2 activity through Ca 2+ and cAMP pathways. Am J Physiol Endocrinol Metab 2006; 290:E282-E288.
58. Sarkar P, et al: Ontogeny of foetal exposure to maternal cortisol using mid-trimester amniotic fluid as a biomarker. Clin Endocrinol (Oxf) 2007; 66: 636-640.
59. Baibazarova E, et al: Influence of prenatal maternal stress, maternal plasma cortisol and cortisol in the amniotic fluid on birth outcomes and child temperament at
60. months. Psychoneuroendocrinology 2013; 38: 907-915.
61. Owens PC, et al: Postnatal disappearance of the pregnancy-associated reduced sensitivity of plasma cortisol to feedback inhibition. Life Sci 1987; 41: 1745-1750.
62. Magiakou MA, et al: Hypothalamic corticotropin-releasing hormone suppression during the postpartum period: Implications for the increase in psychiatric manifestations at this time. J Clin Endocrinol Metab 1996; 81: 1912-1917.
63. O'Keane V, et al: Changes in the maternal hypothalamic-pituitary-adrenal axis during the early puerperium may be related to the postpartum 'blues'. J Neuroendocrinol 2011; 23: 1149-1155.
64. Davis EP, Sandman CA: The timing of prenatal exposure to maternal cortisol and psychosocial stress is associated with human infant cognitive development. Child Dev 2010; 81: 131-148.
65. Voegtline KM, et al: Concurrent levels of maternal salivary cortisol are unrelated to selfreported psychological measures in low-risk pregnant women. Arch Womens Ment Health 2013; 16: 101-108.
66. Talge NM, Neal C, Glover V: Antenatal maternal stress and long-term effects on child neurodevelopment: how and why? J Child Psychol Psychiatry 2007; 48: 245-261.
67. Harville EW, et al: Stress questionnaires and stress biomarkers during pregnancy. J Womens Health (Larchmt) 2009; 18: 1425-1433.
68. Wadhwa PD, et al: The contribution of maternal stress to preterm birth: Issues and considerations. Clin Perinatol 2011; 38: 351-384.
69. Pluess M, et al: Positive life events predict salivary cortisol in pregnant women. Psychoneuroendocrinology 2012; 37: 1336-1340.
70. Bublitz MH, Stroud LR: Childhood sexual abuse is associated with cortisol awakening response over pregnancy: Preliminary findings. Psychoneuroendocrinology 2012; 37: 1425-1430.
71. Obel C, et al: Stress and salivary cortisol during pregnancy. Psychoneuroendocrinology 2005; 30: 647-656.
72. D'Anna-Hernandez KL, et al: Acculturation, maternal cortisol, and birth outcomes in women of Mexican descent. Psychosom Med 2012; 74: 296-304.
73. Raikkonen K, et al: Lower maternal socioeconomic position increase the placental glucocorticoid sensitivity and transfer. Eur J Psychotraumatol 2012;3(suppl 1):19554.
74. Vianna P, et al: Distress conditions during pregnancy may lead to pre-eclampsia by increasing cortisol levels and altering lymphocyte sensitivity to glucocorticoids. Med Hypotheses 2011; 77: 188-191.
75. Schoof E, et al: Decreased gene expression of 11-hydroxysteroid dehydrogenase type 2 and 15-hydroxyprostaglandin dehydrogenase in human placenta of patients with preeclampsia. J Clin Endocrinol Metab 2001; 86: 1313-1317.
76. Langley-Evans SC, et al: Protein intake in pregnancy, placental glucocorticoid metabolism and the programming of hypertension in the rat. Placenta 1996; 17: 169-172.
77. Gardner DS, Jackson AA, Langley-Evans SC: Maintenance of maternal diet-induced hypertension in the rat is dependent on glucocorticoids. Hypertension 1997; 30: 1525-1530.
78. Jiang X, et al: Maternal choline intake alters the epigenetic state of fetal cortisol-regulating genes in humans. FASEB J 2012; 26: 3563-3574.
79. Herrmann TS, et al: Prolonged periods without food intake during pregnancy increase risk for elevated maternal corticotropin-releasing hormone concentrations. Am J Obstet Gynecol 2001; 185: 403-412.
80. Reinisch JM, et al: Prenatal exposure to prednisone in humans and animals retards intrauterine growth. Science 1978; 202: 436-438.
81. Novy MJ, Walsh SW: Dexamethasone and estradiol treatment in pregnant rhesus macaques: effects on gestation length, maternal plasma hormones and fetal growth. Am J Obstet Gynecol 1983; 145: 920-930.
82. Mosier HD Jr, et al: Disproportionate growth of organs and body weight following glucocorticoid treatment of the rat fetus. Dev Pharmacol Ther 1982; 4: 89-105.
83. Alexander N, et al: Impact of antenatal synthetic glucocorticoid exposure on endocrine stress reactivity in term born children. J Clin Endocrinol Metab 2012; 97: 3538-3544.
84. Bloom SL, et al: Antenatal dexamethasone and decreased birth weight. Obstet Gynecol 2001; 97: 485-490.
85. Roberts D, Dalziel S: Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006; 3:CD004454.
86. Diego MA, et al: Maternal psychological distress, prenatal cortisol, and fetal weight. Psychosom Med 2006; 68: 747-753.
87. Li J, et al: Late gestational maternal serum cortisol is inversely associated with fetal brain growth. Neurosci Biobehav Rev 2012; 36: 1085-1092.
88. Goedhart G, et al: Maternal cortisol and offspring birth weight: results from a large prospective cohort study. Psychoneuroendocrinology 2010; 35: 644-652.
89. Bolten MI, et al: Cortisol levels in pregnancy as a psychobiological predictor for birth weight. Arch Womens Ment Health 2011; 14: 33-41.
90. Hompes T, et al: The influence of maternal cortisol and emotional state during pregnancy on fetal intrauterine growth. Pediatr Res 2012; 72: 305-315.
91. Hobel CJ, Arora CP, Korst LM: Corticotrophin-releasing hormone and CRH-binding protein. Differences between patients at risk for preterm birth and hypertension. Ann NY Acad Sci 1999; 897: 54-65.
92. Mancuso RA, et al: Maternal prenatal anxiety and corticotropin-releasing hormone associated with timing of delivery. Psychosom Med 2004; 66: 762-769.
93. Sandman CA, et al: Elevated maternal cortisol early in pregnancy predicts third trimester levels of placental corticotropin-releasing hormone: Priming the placental clock. Peptides 2006; 27: 1457-1463.
94. Buss C, et al: The maternal cortisol awakening response in human pregnancy is associated with the length of gestation. Am J Obstet Gynecol 2009; 201: 398.e1-e8.
95. Kramer MS, et al: Stress pathways to spontaneous preterm birth: The role of stressors, psychological distress, and stress hormones. Am J Epidemiol 2009; 169: 1319-1326.
96. Strandberg TE, et al: Preterm birth and licorice consumption during pregnancy. Am J Epidemiol 2002; 156: 803-805.
97. McTernan CL, et al: Reduced placental 11-hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: An analysis of possible mechanisms. J Clin Endocrinol Metab 2001; 86: 4979-4983.
98. Kajantie E, et al: Placental 11-hydroxysteroid dehydrogenase-2 and fetal cortisol/cortisone shuttle in small preterm infants. J Clin Endocrinol Metab 2003; 88: 493-500.
99. Dave-Sharma S, et al: Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess. J Clin Endocrinol Metab 1998; 83: 2244-2254.
100. Smith AK, et al: Predictors of neonatal hypothalamic-pituitary-adrenal axis activity at delivery. Clin Endocrinol (Oxf) 2011;75:90-95.
101. Davis EP, et al: Prenatal maternal stress programs infant stress regulation. J Child Psychol Psychiatry 2011; 52: 119-129.
102. Phillips DI, et al: Elevated plasma cortisol concentrations: A link between low birth weight and the insulin resistance syndrome? J Clin Endocrinol Metab 1998; 83: 757-760.
103. Phillips DI, et al: Low birth weight predicts elevated plasma cortisol concentrations in adults from 3 populations. Hypertension 2000; 35: 1301-1306.
104. Van Montfoort N, et al: Could cortisol explain the association between birth weight and cardiovascular disease in later life? A meta-analysis. Eur J Endocrinol 2005; 153: 811-817.
105. Reynolds RM, et al: Altered control of cortisol secretion in adult men with low birth weight and cardiovascular risk factors. J Clin Endocrinol Metab 2001; 86: 245-250.
106. Reynolds RM, et al: Is there a gender difference in the associations of birth weight and adult hypothalamic-pituitary-adrenal axis activity? Eur J Endocrinol 2005; 152: 249-253.
107. French NP, et al: Repeated antenatal corticosteroids: Size at birth and subsequent development. Am J Obstet Gynecol 1999; 180: 114-121.
108. Austin MP, Leader LR, Reilly N: Prenatal stress, the hypothalamic-pituitary-adrenal axis, and fetal and infant neurobehaviour. Early Hum Dev 2005; 81: 917-926.
109. Huizink AC, et al: Stress during pregnancy is associated with developmental outcome in infancy. J Child Psychol Psychiatry 2003; 44: 810-818.
110. Gutteling BM, et al: The effects of prenatal stress on temperament and problem behavior of 27-month-old toddlers. Eur Child Adolesc Psychiatry 2005; 14: 41-51.
111. Bergman K, et al: Maternal prenatal cortisol and infant cognitive development: moderation by infant-mother attachment. Biol Psychiatry 2010; 67: 1026-1032.
112. Raikkonen K, et al: Maternal licorice consumption and detrimental cognitive and psychiatric outcomes in children. Am J Epidemiol 2009; 170: 1137-1146.
113. Raikkonen K, et al: Maternal prenatal licorice consumption alters hypothalamic-pituitary-adrenocortical axis function in children. Psychoneuroendocrinology 2010; 35: 1587-1593.
114. Buss C, et al: Maternal cortisol over the course of pregnancy and subsequent child amygdala and hippocampus volumes and affective problems. Proc Natl Acad Sci USA 2012; 109:E1312-E1319.
115. Buss C, et al: High pregnancy anxiety during mid-gestation is associated with decreased gray matter density in 6-to 9-year-old children. Psychoneuroendocrinology 2010; 35: 141-153.
116. Dalziel SR, et al: Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial. Lancet 2005; 365: 1856-1862.
117. Huh SY, et al: Association between umbilical cord glucocorticoids and blood pressure at age 3 years. BMC Med 2008; 6: 25.
118. Van Dijk AE, et al: The relation of maternal job strain and cortisol levels during early pregnancy with body composition later in the 5-year-old child: The ABCD study. Early Hum Dev 2012; 88: 351-356.
119. Majzoub JA, et al: A central theory of preterm and term labor: Putative role for corticotropin-releasing hormone. Am J Obstet Gynecol 1999; 180:S232-S241.
120. Ellman LM, et al: Timing of fetal exposure to stress hormones: effects on newborn physical and neuromuscular maturation. Dev Psychobiol 2008; 50: 232-241.
121. Melchiorre K, et al: Preeclampsia is associated with persistent postpartum cardiovascular impairment. Hypertension 2011; 58: 709-715.
122. Harville EW, et al: Combined effects of Hurricane Katrina and Hurricane Gustav on the mental health of mothers of small children. J Psychiatr Ment Health Nurs 2011; 18: 288-296.
123. Albus M, Ackenheil M, Engel RR, Muller F: Situational reactivity of autonomic functions in schizophrenic patients. Psychiatry Res 1982; 6: 361-370.
124. Gallagher P, Watson S, Smith MS, Young AH, Ferrier N: Plasma cortisol-dehydroepiandrosterone ratios in schizophrenia and bipolar disorder. Schizphr Res 2007; 90: 258-265.
125. Gil-Ad I, Dickerman Z, Amdursky S, Laron Z: Diurnal rhythm of plasma-endorphin, cortisol and growth hormone in schizophrenics as compared to control subjects. Psychopharmacology 1986; 88: 496-499.
126. Meewisse ML, Reitsma JB, de Vries GJ, Gersons BPR, Olff M: Cortisol and post-traumatic stress disorder in adults: Systematic review and meta-analysis. Br J Psychiatry 2007; 191: 387-392.
127. Muck-Seler D, Pivac N, Jakovljevic M, Brzovic Z: Platelet serotonin, plasma cortisol, and dexamethasone suppression test in schizophrenic patients. Biol Psychiatry 1999; 45: 1433-1439.
128. Muck-Seler D, Pivac N, Mustapic M, Crncevic Z, Jakovljevic M, Sagud M: Platelet serotonin and plasma prolactin and cortisol in healthy, depressed and schizophrenic women. Psychiatry Res 2004; 127: 217-226.
129. Yilmaz N, Herken H, Cicek HK, Celik A, Yurekli M, Akyol O: Increased levels of nitric oxide, cortisol and adrenomedullin in patients with chronic schizophrenia. Med Princ Pract 2007; 16: 137-141.
130. Shirayama Y, Hashimoto K, Suzuki Y, Higuchi T: Correlation of plasma neurosteroid levels to the severity of negative symptoms in male patients with schizophrenia. Schizphr Res 2002; 58: 69-74.
131. Reynolds RM, Strachan MW, Braun A, Fowkes FG, Lee AJ, et al: Elevated fasting plasma cortisol is associated with ischemic heart disease and its risk factors in people with type 2 diabetes: The Edinburgh type 2 diabetes study. J Clin Endocrinol Metab 2010; 95: 1602-1608.
132. Nierop A, et al: Are stress-induced cortisol changes during pregnancy associated with postpartum depressive symptoms? Psychosom Med 2006; 68: 931-937.
133. Yim IS, et al: Risk of postpartum depressive symptoms with elevated corticotropin-releasing hormone in human pregnancy. Arch Gen Psychiatry 2009; 66: 162-169.
134. Okano T, Nomura J: Endocrine study of the maternity blues. Prog Neuropsychopharmacol Biol Psychiatry 1992; 16: 921-932.
135. Ehlert U, et al: Postpartum blues: Salivary cortisol and psychological factors. J Psychosom Res 1990; 34: 319-325.
136. Labad J, et al: Increased morning adrenocorticotrophin hormone levels in women with postpartum thoughts of harming the infant. Psychoneuroendocrinology 2011; 36: 924-928.
137. Urizar GG Jr, et al: Impact of stress reduction instructions on stress and cortisol levels during pregnancy. Biol Psychol 2004; 67: 275-282.
138. Liu D, et al: Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. Science 1997; 277: 1659-1662.
139. Caldji C, et al: Maternal care during infancy regulates the development of neural systems mediating the expression of fearfulness in the rat. Proc Natl Acad Sci USA 1998; 95: 5335-5340.
140. Francis D, et al: Nongenomic transmission across generations of maternal behavior and stress responses in the rat. Science 1999; 286: 1155-1158.
141. Alikhani-Koopaei R, et al: Epigenetic regulation of 11-hydroxysteroid dehydrogenase type 2 expression. J Clin Invest 2004; 114: 1146-1157.
142. Marsit CJ, et al: Placental 11-hydroxysteroid dehydrogenase methylation is associated with newborn growth and a measure of neurobehavioral outcome. PLoS One 2012; 7: e33794.